Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 1096385, 12 pages
https://doi.org/10.1155/2017/1096385
Review Article

High Circulating Levels of ANGPTL2: Beyond a Clinical Marker of Systemic Inflammation

1Faculty of Medicine, Montreal Heart Institute, Montreal, QC, Canada
2Department of Surgery, Montreal University, Montreal, QC, Canada

Correspondence should be addressed to Nathalie Thorin-Trescases; gro.ihm-mci@sesacsert.eilahtan

Received 29 May 2017; Revised 25 July 2017; Accepted 2 August 2017; Published 24 August 2017

Academic Editor: Mark Crabtree

Copyright © 2017 Nathalie Thorin-Trescases and Eric Thorin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Santulli, “Angiopoietin-like proteins: a comprehensive look,” Frontiers in Endocrinology (Lausanne), vol. 5, p. 4, 2014. View at Publisher · View at Google Scholar
  2. I. Kim, S. O. Moon, K. N. Koh et al., “Molecular cloning, expression, and characterization of angiopoietin-related protein. Angiopoietin-related protein induces endothelial cell sprouting,” The Journal of Biological Chemistry, vol. 274, no. 37, pp. 26523–26528, 1999. View at Google Scholar
  3. H. Odagiri, T. Kadomatsu, M. Endo et al., “The secreted protein ANGPTL2 promotes metastasis of osteosarcoma cells through integrin alpha5beta1, p38 MAPK, and matrix metalloproteinases,” Science Signaling, vol. 7, no. 309, article ra7, 2014. View at Google Scholar
  4. T. Kadomatsu, M. Tabata, and Y. Oike, “Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases,” The FEBS Journal, vol. 278, no. 4, pp. 559–564, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Tabata, T. Kadomatsu, S. Fukuhara et al., “Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance,” Cell Metabolism, vol. 10, no. 3, pp. 178–188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Thorin-Trescases and E. Thorin, “Angiopoietin-like-2: a multifaceted protein with physiological and pathophysiological properties,” Expert Reviews in Molecular Medicine, vol. 16, article e17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. J. F. Larouche, C. Yu, X. Luo et al., “Acute high-intensity intermittent aerobic exercise reduces plasma angiopoietin-like 2 in patients with coronary artery disease,” The Canadian Journal of Cardiology, vol. 31, no. 10, pp. 1232–1239, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Thorin-Trescases, D. Hayami, C. Yu et al., “Exercise lowers plasma angiopoietin-like 2 in men with post-acute coronary syndrome,” PLoS One, vol. 11, no. 10, article e0164598, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Usui, T. Ninomiya, M. Nagata et al., “Angiopoietin-like protein 2 is associated with chronic kidney disease in a general Japanese population: the Hisayama study,” Circulation Journal, vol. 77, no. 9, pp. 2311–2317, 2013. View at Google Scholar
  10. T. Kadomatsu, M. Endo, K. Miyata, and Y. Oike, “Diverse roles of ANGPTL2 in physiology and pathophysiology,” Trends in Endocrinology and Metabolism, vol. 25, no. 5, pp. 245–254, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Hato, M. Tabata, and Y. Oike, “The role of angiopoietin-like proteins in angiogenesis and metabolism,” Trends in Cardiovascular Medicine, vol. 18, no. 1, pp. 6–14, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Oike, K. Yasunaga, and T. Suda, “Angiopoietin-related/angiopoietin-like proteins regulate angiogenesis,” International Journal of Hematology, vol. 80, no. 1, pp. 21–28, 2004. View at Google Scholar
  13. Y. Kubota, Y. Oike, S. Satoh et al., “Cooperative interaction of angiopoietin-like proteins 1 and 2 in zebrafish vascular development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 38, pp. 13502–13507, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. A. M. Buga, C. Margaritescu, C. J. Scholz, E. Radu, C. Zelenak, and A. Popa-Wagner, “Transcriptomics of post-stroke angiogenesis in the aged brain,” Frontiers in Aging Neuroscience, vol. 6, p. 44, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Fan, P. Shi, J. Dai et al., “Paired immunoglobulin-like receptor B regulates platelet activation,” Blood, vol. 124, no. 15, pp. 2421–2430, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. M. R. Richardson, E. P. Robbins, S. Vemula et al., “Angiopoietin-like protein 2 regulates endothelial colony forming cell vasculogenesis,” Angiogenesis, vol. 17, no. 3, pp. 675–683, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Akhter, M. M. Rahman, H. S. Lee, H. J. Kim, and S. T. Hong, “Dynamic roles of angiopoietin-like proteins 1, 2, 3, 4, 6 and 7 in the survival and enhancement of ex vivo expansion of bone-marrow hematopoietic stem cells,” Protein & Cell, vol. 4, no. 3, pp. 220–230, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. H. E. Broxmeyer, E. F. Srour, S. Cooper, C. T. Wallace, G. Hangoc, and B. S. Youn, “Angiopoietin-like-2 and -3 act through their coiled-coil domains to enhance survival and replating capacity of human cord blood hematopoietic progenitors,” Blood Cells, Molecules & Diseases, vol. 48, no. 1, pp. 25–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Deng, Z. Lu, J. Zheng et al., “A motif in LILRB2 critical for Angptl2 binding and activation,” Blood, vol. 124, no. 6, pp. 924–935, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. M. I. Lin, E. N. Price, S. Boatman et al., “Angiopoietin-like proteins stimulate HSPC development through interaction with notch receptor signaling,” eLife, vol. 4, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. C. C. Zhang, M. Kaba, G. Ge et al., “Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells,” Nature Medicine, vol. 12, no. 2, pp. 240–245, 2006. View at Google Scholar
  22. J. Zheng, M. Umikawa, C. Cui et al., “Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development,” Nature, vol. 485, no. 7400, pp. 656–660, 2012. View at Google Scholar
  23. H. Horiguchi, M. Endo, K. Kawane et al., “ANGPTL2 expression in the intestinal stem cell niche controls epithelial regeneration and homeostasis,” The EMBO Journal, vol. 36, no. 4, pp. 409–424, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Motokawa, M. Endo, K. Terada et al., “Interstitial pneumonia induced by bleomycin treatment is exacerbated in Angptl2-deficient mice,” American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 311, no. 4, pp. L704–L713, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Yugami, H. Odagiri, M. Endo et al., “Mice deficient in angiopoietin-like protein 2 (Angptl2) gene show increased susceptibility to bacterial infection due to attenuated macrophage activity,” The Journal of Biological Chemistry, vol. 291, no. 36, pp. 18843–18852, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Horio, T. Kadomatsu, K. Miyata et al., “Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 4, pp. 790–800, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Aoi, M. Endo, T. Kadomatsu et al., “Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis,” Cancer Research, vol. 71, no. 24, pp. 7502–7512, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Aoi, M. Endo, T. Kadomatsu et al., “Angiopoietin-like protein 2 accelerates carcinogenesis by activating chronic inflammation and oxidative stress,” Molecular Cancer Research, vol. 12, no. 2, pp. 239–249, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Carbone, G. Piro, M. Fassan et al., “An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis,” Oncotarget, vol. 6, no. 15, pp. 13822–13834, 2015. View at Publisher · View at Google Scholar
  30. Y. Chen, H. Jiang, L. Zhu et al., “Diagnostic and prognostic value of serum angiopoietin-like protein 2 in patients with non-small cell lung cancer,” Clinical Laboratory, vol. 63, no. 1, pp. 59–65, 2017. View at Publisher · View at Google Scholar
  31. M. Endo, M. Nakano, T. Kadomatsu et al., “Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis,” Cancer Research, vol. 72, no. 7, pp. 1784–1794, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Endo, Y. Yamamoto, M. Nakano et al., “Serum ANGPTL2 levels reflect clinical features of breast cancer patients: implications for the pathogenesis of breast cancer metastasis,” The International Journal of Biological Markers, vol. 29, no. 3, pp. e239–e245, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Gao, C. Ge, T. Fang et al., “ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma,” Journal of Gastroenterology and Hepatology, vol. 30, no. 2, pp. 396–404, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Ide, Y. Toiyama, T. Shimura et al., “Angiopoietin-like protein 2 acts as a novel biomarker for diagnosis and prognosis in patients with esophageal cancer,” Annals of Surgical Oncology, vol. 22, no. 8, pp. 2585–2592, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Sasaki, A. Suzuki, M. Shitara et al., “Angiopoietin-like protein ANGPTL2 gene expression is correlated with lymph node metastasis in lung cancer,” Oncology Letters, vol. 4, no. 6, pp. 1325–1328, 2012. View at Google Scholar
  36. R. Sato, M. Yamasaki, K. Hirai et al., “Angiopoietin-like protein 2 induces androgen-independent and malignant behavior in human prostate cancer cells,” Oncology Reports, vol. 33, no. 1, pp. 58–66, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Shimura, Y. Toiyama, K. Tanaka et al., “Angiopoietin-like protein 2 as a predictor of early recurrence in patients after curative surgery for gastric cancer,” Anticancer Research, vol. 35, no. 9, pp. 4633–4639, 2015. View at Publisher · View at Google Scholar
  38. Y. Toiyama, Y. Inoue, T. Shimura et al., “Serum angiopoietin-like protein 2 improves preoperative detection of lymph node metastasis in colorectal cancer,” Anticancer Research, vol. 35, no. 5, pp. 2849–2856, 2015. View at Google Scholar
  39. Y. Toiyama, K. Tanaka, T. Kitajima et al., “Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients,” Carcinogenesis, vol. 36, no. 12, pp. 1474–1483, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Toiyama, K. Tanaka, T. Kitajima et al., “Elevated serum angiopoietin-like protein 2 correlates with the metastatic properties of colorectal cancer: a serum biomarker for early diagnosis and recurrence,” Clinical Cancer Research, vol. 20, no. 23, pp. 6175–6186, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Yoshinaga, T. Shigemitsu, H. Nishimata et al., “Angiopoietin-like protein 2 as a potential biomarker for colorectal cancer,” Molecular and Clinical Oncology, vol. 3, no. 5, pp. 1080–1084, 2015. View at Google Scholar
  42. T. Yoshinaga, T. Shigemitsu, H. Nishimata, T. Takei, and M. Yoshida, “Angiopoietin-like protein 2 is a potential biomarker for gastric cancer,” Molecular Medicine Reports, vol. 11, no. 4, pp. 2653–2658, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Zhou, J. Wang, S. Wu et al., “Angiopoietin-like protein 2 negatively regulated by microRNA-25 contributes to the malignant progression of colorectal cancer,” International Journal of Molecular Medicine, vol. 34, no. 5, pp. 1286–1292, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Doi, T. Ninomiya, Y. Hirakawa et al., “Angiopoietin-like protein 2 and risk of type 2 diabetes in a general Japanese population: the Hisayama study,” Diabetes Care, vol. 36, no. 1, pp. 98–100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. B. Gellen, N. Thorin-Trescases, P. Sosner et al., “ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients,” Diabetologia, vol. 59, no. 11, pp. 2321–2330, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. Q. Li, W. Gong, Z. Yang et al., “Serum Angptl2 levels are independently associated with albuminuria in type 2 diabetes,” Diabetes Research and Clinical Practice, vol. 100, no. 3, pp. 385–390, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Zhang, S. Lu, and R. Li, “Association between maternal serum concentrations of angiopoietin-like protein 2 in early pregnancy and subsequent risk of gestational diabetes mellitus,” Chinese Medical Journal, vol. 129, no. 19, pp. 2308–2312, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. M. P. Desjardins, N. Thorin-Trescases, A. Sidibé et al., “Levels of angiopoietin-like-2 are positively associated with aortic stiffness and mortality after kidney transplantation,” American Journal of Hypertension, vol. 30, no. 4, pp. 409–416, 2017. View at Publisher · View at Google Scholar
  49. J. Morinaga, T. Kadomatsu, K. Miyata et al., “Angiopoietin-like protein 2 increases renal fibrosis by accelerating transforming growth factor-beta signaling in chronic kidney disease,” Kidney International, vol. 89, no. 2, pp. 327–341, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. N. Farhat, N. Thorin-Trescases, M. Mamarbachi et al., “Angiopoietin-like 2 promotes atherogenesis in mice,” Journal of the American Heart Association, vol. 2, no. 3, article e000201, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Hata, N. Mukai, M. Nagata et al., “Serum angiopoietin-like protein 2 is a novel risk factor for cardiovascular disease in the community: the Hisayama study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 36, no. 8, pp. 1686–1691, 2016. View at Publisher · View at Google Scholar · View at Scopus
  52. C. L. Huang, Y. W. Wu, C. C. Wu, J. J. Hwang, and W. S. Yang, “Serum angiopoietin-like protein 2 concentrations are independently associated with heart failure,” PLoS One, vol. 10, no. 9, article e0138678, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. C. H. Jung, W. J. Lee, M. J. Lee et al., “Association of serum angiopoietin-like protein 2 with carotid intima-media thickness in subjects with type 2 diabetes,” Cardiovascular Diabetology, vol. 14, p. 35, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Nguyen, M. Mamarbachi, V. Turcot et al., “Lower methylation of the ANGPTL2 gene in leukocytes from post-acute coronary syndrome patients,” PLoS One, vol. 11, no. 4, article e0153920, 2016. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Oike and M. Tabata, “Angiopoietin-like proteins—potential therapeutic targets for metabolic syndrome and cardiovascular disease,” Circulation Journal, vol. 73, no. 12, pp. 2192–2197, 2009. View at Google Scholar
  56. H. Tazume, K. Miyata, Z. Tian et al., “Macrophage-derived angiopoietin-like protein 2 accelerates development of abdominal aortic aneurysm,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 6, pp. 1400–1409, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. Z. Wang, H. Zheng, H. Chen et al., “Elevated serum angiopoietin-like protein 2 in patients with acute coronary syndrome,” Archives of Medical Research, vol. 46, no. 4, pp. 257–264, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. Q. X. Meng, L. Wen, X. Y. Chen, and H. J. Zhong, “Association of serum angiopoietin-like protein 2 and epinephrine levels in metabolically healthy but obese individuals: and evidence,” Experimental and Therapeutic Medicine, vol. 5, no. 6, pp. 1631–1636, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Muramoto, K. Tsushita, A. Kato et al., “Angiopoietin-like protein 2 sensitively responds to weight reduction induced by lifestyle intervention on overweight Japanese men,” Nutrition & Diabetes, vol. 1, article e20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. M.-E. Piché, N. Thorin-Trescases, A. Auclair et al., “Bariatric surgery-induced lower angiopoietin-like 2 protein is associated with improved cardiometabolic profile,” The Canadian Journal of Cardiology, vol. 33, no. 8, pp. 1044–1051, 2017. View at Publisher · View at Google Scholar
  61. A. Ogata, M. Endo, J. Aoi et al., “The role of angiopoietin-like protein 2 in pathogenesis of dermatomyositis,” Biochemical and Biophysical Research Communications, vol. 418, no. 3, pp. 494–499, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Okada, H. Tsukano, M. Endo et al., “Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis,” The American Journal of Pathology, vol. 176, no. 5, pp. 2309–2319, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Horiguchi, M. Endo, Y. Miyamoto et al., “Angiopoietin-like protein 2 renders colorectal cancer cells resistant to chemotherapy by activating spleen tyrosine kinase-phosphoinositide 3-kinase-dependent anti-apoptotic signaling,” Cancer Science, vol. 105, no. 12, pp. 1550–1559, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. D. F. Guo, I. Chenier, V. Tardif, S. N. Orlov, and T. Inagami, “Type 1 angiotensin II receptor-associated protein ARAP1 binds and recycles the receptor to the plasma membrane,” Biochemical and Biophysical Research Communications, vol. 310, no. 4, pp. 1254–1265, 2003. View at Google Scholar
  65. D. F. Guo, Y. L. Sun, P. Hamet, and T. Inagami, “The angiotensin II type 1 receptor and receptor-associated proteins,” Cell Research, vol. 11, no. 3, pp. 165–180, 2001. View at Publisher · View at Google Scholar
  66. N. Ouchi, J. L. Parker, J. J. Lugus, and K. Walsh, “Adipokines in inflammation and metabolic disease,” Nature Reviews. Immunology, vol. 11, no. 2, pp. 85–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. Z. Tian, K. Miyata, H. Tazume et al., “Perivascular adipose tissue-secreted angiopoietin-like protein 2 (Angptl2) accelerates neointimal hyperplasia after endovascular injury,” Journal of Molecular and Cellular Cardiology, vol. 57, pp. 1–12, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. Z. Tian, K. Miyata, T. Kadomatsu et al., “ANGPTL2 activity in cardiac pathologies accelerates heart failure by perturbing cardiac function and energy metabolism,” Nature Communications, vol. 7, article 13016, 2016. View at Publisher · View at Google Scholar · View at Scopus
  69. H. Sun, J. M. Zheng, S. Chen, C. H. Zeng, Z. H. Liu, and L. S. Li, “Enhanced expression of ANGPTL2 in the microvascular lesions of diabetic glomerulopathy,” Nephron Experimental Nephrology, vol. 105, no. 4, pp. e117–e123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. H. Nishi, “Angiopoietin-like protein 2 and kidney fibrosis: lessons from knockout mice,” Kidney International, vol. 89, no. 2, pp. 272–274, 2016. View at Publisher · View at Google Scholar · View at Scopus
  71. S. David, P. Kümpers, J. Hellpap et al., “Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation,” American Journal of Kidney Diseases, vol. 53, no. 5, pp. 770–778, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. S. David, P. Kümpers, A. Lukasz et al., “Circulating angiopoietin-2 levels increase with progress of chronic kidney disease,” Nephrology, Dialysis, Transplantation, vol. 25, no. 8, pp. 2571–2576, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. L. Swain, M. Wottawa, A. Hillemann et al., “Prolyl-4-hydroxylase domain 3 (PHD3) is a critical terminator for cell survival of macrophages under stress conditions,” Journal of Leukocyte Biology, vol. 96, no. 3, pp. 365–375, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. T. Amadatsu, J. Morinaga, T. Kawano et al., “Macrophage-derived angiopoietin-like protein 2 exacerbates brain damage by accelerating acute inflammation after ischemia-reperfusion,” PLoS One, vol. 11, no. 11, article e0166285, 2016. View at Publisher · View at Google Scholar · View at Scopus
  75. N. Farhat, N. Thorin-Trescases, G. Voghel et al., “Stress-induced senescence predominates in endothelial cells isolated from atherosclerotic chronic smokers,” Canadian Journal of Physiology and Pharmacology, vol. 86, no. 11, pp. 761–769, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. C. Yu, X. Luo, N. Farhat et al., “Lack of angiopoietin-like-2 expression limits the metabolic stress induced by a high-fat diet and maintains endothelial function in mice,” Journal of the American Heart Association, vol. 3, no. 4, article e001024, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Shimomura, J. Oyama, M. Takeuchi et al., “Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (statin for acute myocardial infarction trial),” Heart and Vessels, vol. 31, no. 10, pp. 1583–1589, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Pienimaeki-Roemer, T. Konovalova, M. M. Musri et al., “Transcriptomic profiling of platelet senescence and platelet extracellular vesicles,” Transfusion, vol. 57, no. 1, pp. 144–156, 2017. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Shimamoto, H. Kagawa, K. Zensho et al., “Reprogramming suppresses premature senescence phenotypes of Werner syndrome cells and maintains chromosomal stability over long-term culture,” PLoS One, vol. 9, no. 11, article e112900, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. L. Massip, C. Garand, E. R. Paquet et al., “Vitamin C restores healthy aging in a mouse model for Werner syndrome,” The FASEB Journal, vol. 24, no. 1, pp. 158–172, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. J. C. Acosta, A. Banito, T. Wuestefeld et al., “A complex secretory program orchestrated by the inflammasome controls paracrine senescence,” Nature Cell Biology, vol. 15, no. 8, pp. 978–990, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. J. Campisi, J. K. Andersen, P. Kapahi, and S. Melov, “Cellular senescence: a link between cancer and age-related degenerative disease?” Seminars in Cancer Biology, vol. 21, no. 6, pp. 354–359, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. H. Gu, C. Chen, X. Hao et al., “Sorting protein VPS33B regulates exosomal autocrine signaling to mediate hematopoiesis and leukemogenesis,” The Journal of Clinical Investigation, vol. 126, no. 12, pp. 4537–4553, 2016. View at Publisher · View at Google Scholar · View at Scopus
  84. L. Milane, A. Singh, G. Mattheolabakis, M. Suresh, and M. M. Amiji, “Exosome mediated communication within the tumor microenvironment,” Journal of Controlled Release, vol. 219, pp. 278–294, 2015. View at Publisher · View at Google Scholar · View at Scopus